Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell × orelabrutinib × Clear all

NCT05014100 2021-08-27

Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma

Phase 2 Unknown

Lymphoma, B-Cell